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Introduction
Primary angle-closure glaucoma (PACG) is a major
form of glaucoma in Asia.1,2 Nd:YAG laser iridotomy
to relieve pupillary block is safe and effective in treating
or preventing angle-closure glaucoma.3–6 However, 
recent studies showed that the long-term follow-up of
laser peripheral iridotomy might not be satisfactory.7,8
The aims of this study were to evaluate the long-term
effect of Nd:YAG laser iridotomy on intraocular pres-
sure (IOP) in Taiwanese patients with PACG and to
compare the results of chronic angle-closure glaucoma
(CACG) and acute angle-closure glaucoma (AACG).
Methods
We reviewed the medical records of all Taiwanese pa-
tients who had been diagnosed with PACG and who had
undergone Nd:YAG laser iridotomy at Taipei Veterans
General Hospital between 1998 and 2002. PACG was
defined as an elevated IOP of more than 21 mmHg,
glaucomatous optic disc changes and compatible visual
field loss in the eye with occludable angle. Glaucoma-
tous optic disc change was defined as a cup-to-disc
ratio > 0.5. Visual field loss was defined as an auto-
matic Humphrey visual field (program 24-2, Swedish
interactive thresholding algorithm standard) showing
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a glaucoma hemifield test “outside normal limits” and
a cluster of 4 contiguous points on the pattern devia-
tion plot depressed at p < 5% level not crossing the
horizontal meridian. Occludable angle was defined as
an angle in which the trabecular meshwork was not
visible for at least 180 degrees without indentation on
gonioscopy.9 There were 2 groups of patients. Patients
with an acute symptomatic episode of angle-closure
were in the AACG group. In all such patients, the
acute episode was treated and resolved after Nd:YAG
laser iridotomy. These eyes were diagnosed to have 
or developed glaucoma during the follow-up period.
Those without previous acute episode were in the
CACG group. Patients with secondary angle-closure
or less than 24 months of follow-up were excluded.
Demographic characteristics, ophthalmic history, dates
and onset of symptoms, details of laser iridotomy, pre-
senting IOP, IOP during the follow-up period, and the
treatment required were all recorded.
Nd:YAG laser iridotomy was performed for all eyes.
The AACG group received medication first, and then
Nd:YAG laser iridotomy when the IOP was lowered
or corneal edema decreased. All patients were treated
with topical 2% pilocarpine and proparacaine preoper-
atively. Laser energy setting was between 2.0 mJ and
4.5 mJ. The iridotomy site was in the supernasal or
supertemporal quadrant of the peripheral iris. Topical
steroid drops were used 4 times daily for 1 week after
Nd:YAG laser iridotomy. Patients continued their
antiglaucoma medication until the clinician evaluated
the IOP change and gonioscopy.
The long-term outcome was evaluated in terms of
IOP and the requirement for additional therapy. After
Nd:YAG laser iridotomy, eyes that developed a rise 
in IOP were started on medication first, followed by
filtering surgery. Trabeculectomy combined with extra-
capsular cataract extraction and intraocular lens implan-
tation were indicated if there was coexisting dense
cataract. To evaluate the effect of Nd:YAG laser irido-
tomy on IOP in eyes with PACG, a rise in IOP during
follow-up was defined as IOP>21mmHg or additional
medicine or surgery required.
The χ2 test or Fisher’s exact test was used to com-
pare the proportions of patients successfully treated
by Nd:YAG laser iridotomy between groups. Mann-
Whitney U test was used to compare the mean inter-
val after Nd:YAG laser iridotomy for a rise in IOP and
initiation of medicine, as well as the time interval to
surgery in the two groups. Kaplan-Meier survival analy-
sis was performed to assess the survival time of the 
2 groups. The time to failure was defined as the need
for further surgery. The log-rank test was applied to
compare the difference in survival times between
groups. Statistical significance was set at p < 0.05. All
data analyses were performed using a commercial sta-
tistical software package, Stata (Stata Corp., College
Station, TX, USA).
Results
A total of 81 PACG patients (130 eyes) treated with
Nd:YAG laser iridotomy met the inclusion criteria.
There were 51 men and 30 women. The mean age of
the patients was 71.8 ± 6.8 years. The mean follow-up
period was 44.1 ± 17.8 months (median, 36 months).
There were 27 eyes in the AACG group and 103 eyes
in the CACG group. The mean presenting IOP was
44.6 ± 12.0 mmHg in the AACG group and 23.1 ±
4.7 mmHg in the CACG group. The mean cup-to-
disc ratio was 0.71 ± 0.17 in the AACG group and
0.68 ± 0.16 in the CACG group. In the AACG group,
most cases presented at the first symptomatic attack,
with 4 cases at the second episode. The duration of
symptoms before consultation was from 3 to 48 hours.
The number of applications for Nd:YAG laser irido-
tomy ranged from 8 to 52 spots. The short-term com-
plications included transient iris bleeding and post-laser
iridotomy IOP spike. IOP increased in approximately
20% of eyes after laser iridotomy. Antiglaucoma med-
ication and oral acetazolamide were given if IOP was
more than 30 mmHg. The IOP spike resolved by the
first week postoperatively.
Twenty-five eyes (92.6%) in the AACG group and
85 eyes (82.5%) in the CACG group developed a sub-
sequent rise in IOP during follow-up after Nd:YAG
laser iridotomy. Only 2 eyes (7.4%) in the AACG group
and 18 eyes (17.5%) in the CACG group were treated
with Nd:YAG laser iridotomy alone without long-term
rise in IOP. Fourteen eyes (51.9%) in the AACG group
and 64 eyes (62.1%) in the CACG group required
further medical treatment to control IOP. There was no
significant difference in the proportion of eyes success-
fully controlled with Nd:YAG laser iridotomy alone
(p = 0.245) or requiring medication (p = 0.332) in the
2 groups. In the AACG group, 11 eyes (40.7%) required
filtering surgery because of poorly controlled IOP. Ten
eyes underwent trabeculectomy, and 1 eye underwent
combined trabeculectomy with cataract extraction and
lens implantation. In the CACG group, surgical inter-
vention was required in 21 eyes (20.4%) to control IOP.
Thirteen eyes underwent trabeculectomy, and 8 eyes
underwent combined trabeculectomy with cataract ex-
traction and lens implantation. The difference in the
proportion of eyes requiring surgery in the 2 groups
was statistically significant (p = 0.029).
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The intervals for the subsequent rise in IOP after
Nd:YAG laser iridotomy for the 110 eyes are shown
in Table 1. Twenty-four eyes (96.0%) in the AACG
group and 73 eyes (85.9%) in the CACG group devel-
oped a rise in IOP requiring medication in the first
month after Nd:YAG laser iridotomy. The mean dura-
tion after Nd:YAG laser iridotomy was 1.1 months
(median, 1 month) in the AACG group and 1.8 months
(median, 1 month) in the CACG group. This difference
was not statistically significant (p = 0.69).
The intervals for requiring filtering surgery after
Nd:YAG laser iridotomy for the 32 eyes are shown in
Table 2. In the AACG group, all eyes underwent sur-
gery within 6 months, while in the CACG group most
eyes required surgery within 1 year. The mean dura-
tion after Nd:YAG laser iridotomy was longer in the
CACG group (9.8 months; median, 5 months) than
in the AACG group (3.2 months; median, 3 months),
but the difference was not statistically significant (p =
0.098). At the time of surgery, the mean IOP was
29.91 ± 5.84 mmHg in the AACG group and 25.14 ±
2.85 mmHg in the CACG group. The most frequent
topical medications were beta-blockers and cholinergics,
followed by alpha-agonists, carbonic anhydrase and
prostaglandins. A few patients were treated with oral
acetazolamide.
Kaplan-Meier survival curves of the 2 groups after
Nd:YAG laser iridotomy to the introduction of filter-
ing surgery are shown in Figure 1. In the AACG group,
the 1-year survival rate was 59.3%, and the rate re-
mained the same at 3 years. In the CACG group, the
1-year, 2-year and 3-year survival rates were 85.4%,
81.5% and 78.8%, respectively. This difference was
statistically significant (p = 0.013).
Discussion
Pupillary block is a significant mechanism causing
angle-closure glaucoma. Nd:YAG laser iridotomy is
effective in widening the drainage angle7,10,11 and reduc-
ing IOP in eyes with primary angle-closure. Primary
angle-closure is conventionally treated with laser periph-
eral iridotomy, followed by antiglaucoma medication,
Table 1. Time interval for rise in intraocular pressure requiring
further treatment after Nd:YAG laser iridotomy
Duration (mo) AACG (n = 25) CACG (n = 85) p*
≤ 1 24 (96.0%) 73 (85.9%)
> 1 to 6 1 (4.0%) 7 (8.2%)
> 6 to 12 0 (0%) 3 (3.5%)
> 12 0 (0%) 2 (2.4%)
Mean 1.1 1.8 0.69
Median 1.0 1.0
*Mann-Whitney U test was used for statistical analysis. AACG = acute angle-
closure glaucoma; CACG = chronic angle-closure glaucoma.
Table 2. Time interval for rise in intraocular pressure requiring
surgical treatment after Nd:YAG laser iridotomy
Duration (mo) AACG (n = 11) CACG (n = 21) p*
≤ 1 5 (45.5%) 5 (23.8%)
> 1 to 6 6 (54.5%) 6 (28.6%)
> 6 to 12 0 (0%) 4 (19.0%)
> 12 0 (0%) 6 (28.6%)
Mean 3.2 9.8 0.098
Median 3.0 5.0
*Mann-Whitney U test was used for statistical analysis. AACG = acute angle-
closure glaucoma; CACG = chronic angle-closure glaucoma.
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Figure 1. Kaplan-Meier survival curves of the 2 groups after laser iridotomy to the introduction of filtering surgery. AACG = acute angle-
closure glaucoma; CACG = chronic angle-closure glaucoma.
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and then surgery if necessary. Previous studies have
shown that laser iridotomy is effective for IOP control
in Caucasians.3,11 However, reports from Asian popu-
lations7,8 showed that Nd:YAG laser iridotomy might
be inadequate to maintain IOP control in the long term.
Nolan et al7 examined 164 eyes of 98 Mongolian 
subjects with primary angle-closure and found that
iridotomy failed in 47% of eyes with established optic
neuropathy. Alsagoff et al8 studied 83 eyes with PACG
of different Asian ethnicities (e.g. Chinese, Malay,
Indian) and found that 53% of eyes became medically
uncontrolled after laser iridotomy. We noted similar
findings, that 40.7% of eyes with AACG and 20.4%
eyes with CACG required filtering surgery because of
poorly controlled IOP. Nd:YAG laser iridotomy alone
may be ineffective for IOP control in most Taiwanese
eyes with PACG.
Compared with Caucasians, Asian eyes are prone
to develop angle-closure.12,13 The biometry in differ-
ent ethnicities may play a significant role. Shorter axial
global length, shallower anterior chamber and greater
than 2 diopters of hyperopia were significantly cor-
related with a diagnosis of PACG.14 Clinically, lens
swelling,15 ciliary block16 and plateau iris17 may be in-
volved in the pathogenesis of primary angle-closure.
Plateau iris has been shown to be poorly responsive to
laser iridotomy.18 In addition to anatomical factors,
laser iridotomy itself may cause progression of periph-
eral anterior synechiae in PACG eyes.19 Also, a higher
energy of Nd:YAG laser is necessary to penetrate thicker
and heavily pigmented Asian irides than Caucasian iri-
des. The pigment release and inflammation might
account for the subsequent IOP rise after Nd:YAG
laser iridotomy in Asians.
Our study showed that eyes with AACG needed
more surgical intervention than eyes with CACG, which
is consistent with earlier reports.8,20 Eyes with AACG
may have had some degree of permanent angle dam-
age and diminished outflow after acute episode. Also,
there is potentially increased angle crowding by pro-
gressive lens swelling. Although the mechanisms caus-
ing alterations in lens metabolism are unknown, more
rapid cataract formation was noted after acute angle-
closure.21,22 Also, Asian eyes tended to have more
severe attacks with longer duration.23 These factors
might contribute to the failure of IOP control and more
surgery needed in AACG eyes.
The present study found that 88.2% of our patients
experienced an IOP rise after Nd:YAG laser iridotomy
within the first month. This is higher than in previous
reports.10,24 Lim et al10 found that 6 eyes (31.6%)
within the first month and 5 eyes (26.3%) between
month 1 and 2 had a rise in IOP in 44 acute primary
angle-closure eyes treated with Nd:YAG laser irido-
tomy. Their patients had acute primary angle-closure
without documented optic neuropathy, while ours had
established glaucomatous optic neuropathy and visual
field loss. Nd:YAG laser iridotomy might worsen the
damage in the trabecular meshwork for advanced glau-
coma with compromised outflow. Another study of an
American population24 reported that 19 eyes (54.3%)
in the AACG group and 18 eyes (45%) in the CACG
group developed elevated IOP within 1 month after
sequential Argon laser and Nd:YAG laser iridotomy.
Elevated IOP shortly after laser warrants close monitor-
ing of PACG patients to avoid further glaucomatous
damage.
This study was limited by the retrospective design,
modest number of cases and variable follow-up. There
was difficulty in documenting standardized gonioscopy
because multiple ophthalmologists were involved in the
treatment of the patients. Also, post-laser iridotomy
IOP spike, different kinds and dosing patterns of drugs
and patient compliance may affect long-term outcome.
However, our study demonstrated the clinical course
of PACG after Nd:YAG laser iridotomy in Taiwanese
eyes. In all patients, Nd:YAG laser iridotomy was per-
formed first, followed by medication and filtering sur-
gery. It seems that long-term IOP control might be
inadequate by Nd:YAG laser iridotomy only, especially
in eyes with AACG. Close monitoring of IOP at fre-
quent intervals after Nd:YAG laser iridotomy is advised
in the follow-up of PACG patients to avoid further
glaucomatous damage.
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